In 2021, the medicated cosmetics accounted for the highest share of the quasi-drugs production in Japan with around 42 percent. That year, the total production value for quasi-drugs in Japan amounted to nearly 1.4 trillion yen.
Share of the quasi-drugs production value in Japan in 2021, by therapeutic category
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Medicated cosmetics production quantity in Japan 2016, by item
- Premium Statistic Quasi drugs production value in Japan 2012-2021
- Premium Statistic Quasi drugs production value in Japan 2021, by therapeutic category
- Premium Statistic Hair remedies production quantity in Japan 2016, by item
- Premium Statistic Pharmaceuticals production value in Colombia 2014-2020
- Premium Statistic Median length of orphan and non-orphan drugs in phase III trial 2015
- Premium Statistic Value added of the pharmaceutical industry in Italy 2000-2022
- Premium Statistic Pharmaceutical industry: top EU import partners 2010-2022
- Premium Statistic Pharmaceutical exports in Mexico 2022, by country
- Premium Statistic Biopharmaceuticals market value in Latin America 2022-2027
About the region
10
- Premium Statistic Hair remedies production amount in Japan 2021, by item
- Premium Statistic Number of prescription drugs approved by PMDA Japan FY 2015-2022, by type
- Premium Statistic Number of BTC and OTC drugs approved by PMDA Japan FY 2013-2022
- Premium Statistic Number of in vitro diagnostics approved by PMDA Japan FY 2013-2022
- Premium Statistic Number of quasi-drugs approved by PMDA Japan FY 2013-2022
- Premium Statistic Production value of medical devices Japan 2012-2021
- Premium Statistic Meiji's pharmaceutical business net sales FY 2013-2022
- Premium Statistic Biosimilar market size Japan 2018-2030
- Premium Statistic R&D expenditure of leading pharmaceutical manufacturers Japan 2020
- Premium Statistic Number of NME approved Japan 2013-2022
Selected statistics
2
Other regions
10
- Basic Statistic Pharmacy revenue share in Sweden 2022, by type of product
- Premium Statistic Colorado's medical cannabis spending 2018-2024
- Basic Statistic Leading orphan drugs in development based on net present value 2023
- Premium Statistic Leading orphan designations in the EU by indication 2015
- Premium Statistic Number of cumulative orphan designations accepted in the U.S. 2003-2018
- Basic Statistic Illinois' medical cannabis sales value U.S. 2018-2024
- Basic Statistic Vermont's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Nevada's medical cannabis spending 2018-2024
- Premium Statistic Massachusetts' medical cannabis spending 2018-2024
- Basic Statistic Maine's medical cannabis spending 2018-2024
Related statistics
10
- Premium Statistic Number of biological drugs approved Japan 2012-2021
- Premium Statistic Number of biosimilars approved by PMDA Japan 2010-2019
- Premium Statistic Pharmaceutical market size Japan 2008-2015
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic OTC drugs market shipment value in Japan 2010-2019
- Premium Statistic Designated quasi drugs market shipment value in Japan 2010-2019
- Premium Statistic Astellas Pharma's net profit FY 2013-2022
- Premium Statistic Sales of medical device and pharmaceutical goods Japan FY 2021, by type
- Premium Statistic Overseas sales of medical device and pharmaceutical goods Japan FY 2021, by type
- Premium Statistic Domestic sales of national medical device and pharma goods Japan FY 2021, by type
Further related statistics
9
- Pfizer's ad spending 2008-2022
- CVS Health's total assets 2005-2022
- Global oil production share 2022, by country
- Global oil production share 2010-2022, by region
- Medicinal market growth worldwide including rebates 2009-2018
- Distribution of ESPRIT employees worldwide by region 2008/2009-2013/2014
- Consumer spending on music at retail in Great Britain (UK) 2013, by age and retailer
- Deaths from secondhand smoke - global distribution by region
- New U.S. donors - retention rate by age and channel
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2008-2022
- CVS Health's total assets 2005-2022
- Global oil production share 2022, by country
- Global oil production share 2010-2022, by region
- Medicinal market growth worldwide including rebates 2009-2018
- Distribution of ESPRIT employees worldwide by region 2008/2009-2013/2014
- Consumer spending on music at retail in Great Britain (UK) 2013, by age and retailer
- Deaths from secondhand smoke - global distribution by region
- New U.S. donors - retention rate by age and channel
MHLW (Japan). (December 23, 2022). Share of the quasi-drugs production value in Japan in 2021, by therapeutic category [Graph]. In Statista. Retrieved December 01, 2023, from https://www.statista.com/statistics/821015/japan-quasi-drug-production-value-distribution-by-therapeutic-category/
MHLW (Japan). "Share of the quasi-drugs production value in Japan in 2021, by therapeutic category." Chart. December 23, 2022. Statista. Accessed December 01, 2023. https://www.statista.com/statistics/821015/japan-quasi-drug-production-value-distribution-by-therapeutic-category/
MHLW (Japan). (2022). Share of the quasi-drugs production value in Japan in 2021, by therapeutic category. Statista. Statista Inc.. Accessed: December 01, 2023. https://www.statista.com/statistics/821015/japan-quasi-drug-production-value-distribution-by-therapeutic-category/
MHLW (Japan). "Share of The Quasi-drugs Production Value in Japan in 2021, by Therapeutic Category." Statista, Statista Inc., 23 Dec 2022, https://www.statista.com/statistics/821015/japan-quasi-drug-production-value-distribution-by-therapeutic-category/
MHLW (Japan), Share of the quasi-drugs production value in Japan in 2021, by therapeutic category Statista, https://www.statista.com/statistics/821015/japan-quasi-drug-production-value-distribution-by-therapeutic-category/ (last visited December 01, 2023)
Share of the quasi-drugs production value in Japan in 2021, by therapeutic category [Graph], MHLW (Japan), December 23, 2022. [Online]. Available: https://www.statista.com/statistics/821015/japan-quasi-drug-production-value-distribution-by-therapeutic-category/